Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Issues Another Consumer Warning About Yellow Oleander - Nutraceuticals World
Market Updates

FDA Issues Another Consumer Warning About Yellow Oleander

The agency first began investigating instances of the toxic botanical appearing in 'tejocote' supplements years ago.

Photo: shivangi | Adobe Stock

The U.S. Food and Drug Administration (FDA) issued another consumer warning about products marketed as “tejocote” being adulterated with a toxic plant called yellow oleander.

The agency first issued a consumer warning in 2023 that weight loss products were associated with yellow oleander, following a joint investigation with the CDC, which found that adulteration was most common in products containing a botanical called Crataegus mexicana, known colloquially as tejocote. The following year, FDA issued another warning following an analysis, concluding that nine “tejocote” supplements it purchased online tested as 100% yellow oleander.

After completing analytical testing of another round of products on Nov. 3, FDA updated its initial report with an additional lineup of products found to be adulterated with yellow oleander. The new products include two products by OBC Group Corp branded as SdB Elite and SdB Semilia de Brasil Tejocote Root, and a product branded as Silueta Ya Mexican Tejocote Roots by Siluetaya, LLC.

According to the agency, “Ingestion of yellow oleander can cause neurologic, gastrointestinal, and cardiovascular adverse health effects that may be severe, or even fatal … symptoms include nausea, vomiting, dizziness, diarrhea, abdominal pain, cardiac changes, dysrhythmia, and more.”

To access FDA’s full report, click here.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters